As of April 2024 Alembic Pharmaceuticals has a market cap of $2.21 Billion. This makes Alembic Pharmaceuticals the world's 3931th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $2.21 B | 23.37% |
2023 | $1.79 B | 32.15% |
2022 | $1.36 B | -35.79% |
2021 | $2.11 B | -23.71% |
2020 | $2.77 B | 83.97% |
2019 | $1.51 B | -6.26% |
2018 | $1.61 B | 3.08% |
2017 | $1.56 B | -5.42% |
2016 | $1.65 B | -16.07% |
2015 | $1.96 B | 48.92% |
2014 | $1.32 B | 105.74% |
2013 | $0.64 B | 158.15% |
2012 | $0.24 B | 97.42% |
2011 | $0.12 B |
On Apr 23rd, 2024 the market cap of Alembic Pharmaceuticals was reported to be: